Ulrich Martin Fuhs - 08 May 2024 Form 4 Insider Report for ALPINE IMMUNE SCIENCES, INC.

Role: Chief Accounting Officer
Signature: /s/ James Paul Rickey, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 08 May 2024
Net transactions value: +$275,437
Form type: 4
Filing time: 10 May 2024, 19:22:43 UTC
Previous filing: 05 Apr 2024
Next filing: 20 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALPN	Common Stock	Options Exercise	$275,437	+22,820	+313%	$12.07	30,120	08 May 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALPN	Stock Option (Right to buy)	Options Exercise	$0	-22,820	-30%	$0.000000	52,180	08 May 2024	Common Stock	22,820	$12.07	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 7,300 shares of common stock underlying a restricted stock unit grant made on March 14, 2024.
F2	1/4th of the shares subject to the option vested on November 30, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the reporting person continuing to be a service provider through each date.